Product information

From Health Canada

Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.

Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.

Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.

New search

Natural Product Number (NPN):
Market status:
Licence Status:
Brand name(s):
Mind-Pro Formula ;
Brain Matrix ;
Ginkgo, Bacopa, GPC, Phosphatidylserine, ALA, B6, B12 & Folic Acid
Licence holder:
CanPrev Natural Health Products Ltd
Dosage Form:
Recommended route of administration:


Recommended dose:
Sub population (Sub Pop.) Quantity (Qty) Frequency (Freq.)
Sub Pop. Age Min. Max. UoM Footnote1 Age Qty Min. Max. UoM Qty Freq. Min. Max. UoM Freq.
Adults 2.0 capsule 2 daily
Recommended use or purpose:
Helps to enhance cognitive function in adults. Helps to support cognitive function. Helps to enhance memory in adults. Helps to support peripheral circulation. Provides antioxidants for the maintenance of good health.
Risk Information:
Cautions and Warnings 
As with any natural health products, you should consult a healthcare practitioner especially if you are taking any medication including high blood pressure medications and seizures medication or have a medical condition including diabetes. Consult a healthcare practitioner prior to use if you are pregnant or breastfeeding. Discontinue use and consult a healthcare practitioner if you experience sweating, paleness, chills, headache, dizziness or confusion - these may be symptoms of serious low blood sugar.
Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding. Do not use if seal is broken. Keep out of reach of children.
Known Adverse Reactions 
May cause digestive problems.
List of medicinal ingredients:
Medicinal ingredients Quantity (Qty) Extract Potency
Bacopa monnieri 37.5 mg
20 : 1
55.0   %
Combined Bacosides A & B
DL-alpha-Lipoic acid 100.0 mg
Folate 200.0 mcg
Ginkgo biloba 40.0 mg
50.000 : 1
DHE: 2000 mg
24.0   %
Flavonoid glycosides
6.0   %
Terpene lactones
L-alpha-Glycerophosphorylcholine 25.0 mg
Phosphatidylserine-enriched Soy lecithin 125.0 mg
20.0   %
Vitamin B12 250.0 mcg
Vitamin B6 6.25 mg
List of non-medicinal ingredients:
  • Beeswax
  • Caramel
  • Fractionated coconut oil
  • Gelatin
  • Glycerin
  • Lecithin
  • Purified water
Date of licensing:
Revised date of licence:

Application information

Related information

Compendium of monographs

Contact us

For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).

Date modified: